COMPANY
COMPANY
Phylumtech is a technology-based company with extensive experience in the sector, created with the goal of providing agile and accessible solutions to everyone in the field of research and drug development. Founded in 2009, Phylumtech is the result of a powerful joint venture between the public and private sectors. A multidisciplinary working team combines the most important aspects of science and research with the current scenario of the 21st century: Biotechnology, Automation, Software, and Bioinformatics.
After many years of work, we have decided to place a strong emphasis on the development of accessible products and solutions that will reach users worldwide. The management of automation and Drug Discovery in the Cloud is our ambitious project, which will be available to researchers, students, and laboratories around the world.
Our vision: Making the process of experimenting and creating compounds easy, fast, with 100% reliable results and proven experimentation.
Our main goal: Optimizing processes and costs to deliver fast, quality, and reliable results in the development and discovery of new molecules.
Phylumtech’s primary focus is on creating agile and effective solutions for discovering new drugs and molecules. We operate in two core business areas:
We work for industry, researchers, laboratories and anyone who has the initiative and curiosity to check the result of a compound.
Dr. Sergio Simonetta
CEO-Founder
Mariano Santa Cruz
CTO-Founder
Dr. Adrian Turjansky
Advisor Bioinformatics
Dr. Marcelo Marti
Advisor Bioinformatics
CITES GSS
Investor
Baufest S.A
Technological partner